Compare BIO & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | DCI |
|---|---|---|
| Founded | 1952 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Pollution Control Equipment |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.1B |
| IPO Year | 1994 | 2005 |
| Metric | BIO | DCI |
|---|---|---|
| Price | $365.91 | $86.55 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 8 |
| Target Price | ★ $356.67 | $100.40 |
| AVG Volume (30 Days) | 232.9K | ★ 515.7K |
| Earning Date | 11-04-2026 | 12-02-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | ★ 142.61 | 26.23 |
| EPS | ★ 11.25 | 3.85 |
| Revenue | $2,583,200,000.00 | ★ $2,844,900,000.00 |
| Revenue This Year | N/A | $7.86 |
| Revenue Next Year | $1.86 | $4.88 |
| P/E Ratio | $32.60 | ★ $22.49 |
| Revenue Growth | 0.65 | ★ 4.05 |
| 52 Week Low | $236.73 | $79.61 |
| 52 Week High | $396.23 | $112.84 |
| Indicator | BIO | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 50.17 |
| Support Level | $354.27 | $85.53 |
| Resistance Level | $391.44 | $89.06 |
| Average True Range (ATR) | 13.26 | 2.14 |
| MACD | -0.39 | 0.33 |
| Stochastic Oscillator | 35.93 | 64.01 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Donaldson is a leading manufacturer of filtration systems and replacement parts, including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors. The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.9 billion in revenue in its fiscal year 2026.